Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Henan Jindan Lactic Acid Technology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.98 |
52 Week High | CN¥25.45 |
52 Week Low | CN¥11.30 |
Beta | 1.26 |
1 Month Change | 3.56% |
3 Month Change | -22.76% |
1 Year Change | -30.55% |
3 Year Change | -58.87% |
5 Year Change | n/a |
Change since IPO | -21.18% |
Recent News & Updates
Shareholder Returns
300829 | CN Chemicals | CN Market | |
---|---|---|---|
7D | -9.6% | -5.3% | -4.9% |
1Y | -30.6% | -27.4% | -16.6% |
Return vs Industry: 300829 underperformed the CN Chemicals industry which returned -25.7% over the past year.
Return vs Market: 300829 underperformed the CN Market which returned -14.8% over the past year.
Price Volatility
300829 volatility | |
---|---|
300829 Average Weekly Movement | 9.0% |
Chemicals Industry Average Movement | 8.0% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 11.5% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 300829's share price has been volatile over the past 3 months.
Volatility Over Time: 300829's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 1,315 | Peixing Yu | https://www.jindanlactic.com |
Henan Jindan Lactic Acid Technology Co.,Ltd. produces and sells lactic acid and lactate products in China. It offers calcium lactate, sodium lactate, potassium lactate, ferrous lactate, lactic acid powder, ethyl and methyl lactate, magnesium lactate, zinc lactate, buffered lactic acid, sodium lactate and sodium diacetate blend, and sodium acetate, as well as corn gluten meals, corn germs, and corn brans that are used in food, medical, feed, industry, and biodegradable applications.
Henan Jindan Lactic Acid Technology Co.,Ltd. Fundamentals Summary
300829 fundamental statistics | |
---|---|
Market cap | CN¥2.89b |
Earnings (TTM) | CN¥119.12m |
Revenue (TTM) | CN¥1.44b |
24.2x
P/E Ratio2.0x
P/S RatioIs 300829 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300829 income statement (TTM) | |
---|---|
Revenue | CN¥1.44b |
Cost of Revenue | CN¥1.19b |
Gross Profit | CN¥255.54m |
Other Expenses | CN¥136.42m |
Earnings | CN¥119.12m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 22, 2024
Earnings per share (EPS) | 0.66 |
Gross Margin | 17.72% |
Net Profit Margin | 8.26% |
Debt/Equity Ratio | 73.8% |
How did 300829 perform over the long term?
See historical performance and comparison